WebMD
•60% Informative
It tends to affect non-Hispa non-Hispanic men and women under 40 more o 40 en.
Treatment depends on the health of the person.
The standard is to take 1 year of immunotherapy fo anti-HER2 s who have stage I TNBC rough III TNBC.
For p âTriple-Negative Breast Cancer within the breast or the lymph nodes at the time of Kevin Kalinsky ot MD rapy is standard TNBC Newer treatments have been recently approved to treat people with early-stage and metastatic TNBC. TNBC pan class="summaryFeed_highLightText__NxlGi">Â âTriple-Negative Breast Cancer More than half /span> sacituzumab govitecan âThe Viewer Questions _highLightText__NxlGi">GPS âYou âHow ightText__NxlGi">PARP breastfeeding?â âIn Talzenna the age of 70 ghtText__NxlGi">talazoparib a HER2 r Lynparza the age of 70 _NxlGi">BRCA TNBC BRCA BRCA PARP Theyâre 2 centimeters PD-L1 Key Itâs a Pembrolizumab Itâs Newer Treatments for Triple-Negative Breast Cancer TNBC an class="summaryFeed_highLightText__NxlGi">HER2 < about 2 years ummaryFeed_highLightText__NxlGi">TNBC HER2 IV HER2 âEstrogen three today Thereâs 2 years 1 a full prognosis?â > the first 5 years > âHowback?â p Itâs lass="summaryFeed_highLightText__NxlGi">2 years 2 weeks 5 years the end of the 5 years those first 2 years the first 5 years Itâs mmaryFeed_highLightText__NxlGi">first
VR Score
53
Informative language
50
Neutral language
45
Article tone
informal
Language
English
Language complexity
38
Offensive language
possibly offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
long-living
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links